Acute Infections and Inflammatory Biomarkers in Patients with Acute Pulmonary Embolism

Although infections are frequent in patients with pulmonary embolism (PE), its effect on adverse outcome risk remains unclear. We investigated the incidence and prognostic impact of infections requiring antibiotic treatment and of inflammatory biomarkers (C-reactive protein [CRP] and procalcitonin [...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggers, Ann-Sophie, Hafian, Alaa, Lerchbaumer, Markus H., Hasenfuß, Gerd, Stangl, Karl, Pieske, Burkert, Lankeit, Mareike, Ebner, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219100/
https://www.ncbi.nlm.nih.gov/pubmed/37240652
http://dx.doi.org/10.3390/jcm12103546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219100/
https://www.ncbi.nlm.nih.gov/pubmed/37240652
http://dx.doi.org/10.3390/jcm12103546

Ejemplares similares